We are live on ! Find out more
CCM

Context Capital Management Portfolio holdings

AUM $5.15B
1-Year Est. Return 1.28%
This Fund
S&P 500
This Quarter Est. Return
+0.35%
1 Year Est. Return
+1.28%
3 Year Est. Return
+3.38%
5 Year Est. Return
+13.56%
10 Year Est. Return
+42.39%
AUM
$1.49B
AUM Growth
+$87.1M
Cap. Flow
-$667M
Cap. Flow %
-44.87%
Top 10 Hldgs %
16.41%
Holding
650
New
22
Increased
4
Reduced
31
Closed
61
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNIXR
351
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$13K ﹤0.01%
210,385
CITEW
352
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$13K ﹤0.01%
100,000
-50,000
-33% -$8.21K
KACLR
353
DELISTED
Kairous Acquisition Corp. Limited Rights
KACLR
$13K ﹤0.01%
180,000
CNGLW
354
DELISTED
Canna-Global Acquisition Corp Warrant
CNGLW
$13K ﹤0.01%
499,500
VCXB.WS
355
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
$13K ﹤0.01%
216,358
NOGNW
356
DELISTED
Nogin, Inc. Warrant
NOGNW
$13K ﹤0.01%
157,100
VENAR
357
DELISTED
Venus Acquisition Corporation Rights
VENAR
$13K ﹤0.01%
44,285
-6,200
-12% -$1.45K
TVGNW icon
358
Tevogen Bio Warrant
TVGNW
$9.64M
$12K ﹤0.01%
98,250
VMCAW
359
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$12K ﹤0.01%
75,000
NVACW
360
DELISTED
NorthView Acquisition Corporation Warrant
NVACW
$12K ﹤0.01%
222,500
CMCAW
361
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$12K ﹤0.01%
137,500
EPWR.WS
362
DELISTED
Empowerment & Inclusion Capital I Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
EPWR.WS
$12K ﹤0.01%
211,721
BRLSW icon
363
Borealis Foods Inc Warrant
BRLSW
$960K
$10K ﹤0.01%
107,878
FTIIW
364
DELISTED
FutureTech II Acquisition Corp. Warrant
FTIIW
$10K ﹤0.01%
150,000
RFACW
365
DELISTED
RF Acquisition Corp. Warrants
RFACW
$10K ﹤0.01%
250,000
RRAC.WS
366
DELISTED
Rigel Resource Acquisition Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RRAC.WS
$10K ﹤0.01%
44,429
LCW.WS
367
DELISTED
Learn CW Investment Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
LCW.WS
$10K ﹤0.01%
87,302
REVEW
368
DELISTED
Alpine Acquisition Corp Warrant
REVEW
$10K ﹤0.01%
71,150
ATA.WS
369
DELISTED
Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50
ATA.WS
$10K ﹤0.01%
154,263
EQHA.WS
370
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$10K ﹤0.01%
125,000
HHGCR
371
DELISTED
HHG Capital Corporation Rights
HHGCR
$10K ﹤0.01%
116,113
-8,787
-7% -$877
AIRJW
372
AirJoule Technologies Warrant
AIRJW
$61.4M
$9K ﹤0.01%
49,977
IGTAW
373
DELISTED
Inception Growth Acquisition Limited Warrants
IGTAW
$9K ﹤0.01%
125,000
MCAAW
374
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$9K ﹤0.01%
153,100
LGVCW
375
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
$9K ﹤0.01%
93,675

Similar funds

Context Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Context Capital Management held 650 positions worth $1.49B, up 6.2% from $1.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Context Capital Management withdrew a net $667M in Q3 2022, closing 61 positions and reducing 31 holdings. Its most notable exit was A SPAC II Acquisition Corp. Unit, an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Context Capital Management opened a new position in A SPAC II Acquisition Corp. Ordinary Shares worth $13.9M.

  • Context Capital Management's largest Q3 2022 buy was A SPAC II Acquisition Corp. Ordinary Shares: 1,400,000 shares worth $13.9M.
  • Context Capital Management added most to Churchill Capital Corp VII Class A Common Stock in Q3 2022, an estimated $4.9M increase.
  • Context Capital Management's biggest Q3 2022 reduction was Aspire Biopharma, cutting an estimated $2.52M.
  • Context Capital Management fully exited A SPAC II Acquisition Corp. Unit in Q3 2022, selling an estimated $14M.
  • Context Capital Management's ten largest holdings make up 16% of its $1.49B portfolio in Q3 2022.
  • Context Capital Management opened 22 new positions and closed 61 in Q3 2022.
  • Context Capital Management's portfolio value rose 6.2% quarter-over-quarter to $1.49B.

Based on Context Capital Management's 13F filing for Q3 2022, filed 7 Nov 2022.